Baricitinib is for adults with moderate to severe active rheumatoid arthritis who haven’t responded well to or can’t tolerate other rheumatoid arthritis drugs. Baricitinib also used for alopecia and COVID-19. It can be used alone or with Methotrexate. Also used Alopecia.

Tofacinix (Tofacitinib) medicine helps to moderate to severe rheumatoid arthritis or active psoriatic arthritis in adults who have tried methotrexate or other medications without successful treatment of symptoms. Tofacinix is sometimes given in combination with methotrexate or other arthritis medicines.

Tofacent 5 is used for treating moderate to severe rheumatoid arthritis (RA). This helps reduce pain, tenderness, and swelling in the joints by reducing inflammation. It also slows down the degeneration of bones and joints. Tofacent 5 may be prescribed alone or in combination with other medications.

Osimertinib is a medication used in the treatment of non-small cell lung cancer (NSCLC), specifically for a type of NSCLC with mutations in the epidermal growth factor receptor (EGFR) gene. This type of mutation is known as the T790M mutation.

Tofacitinib is a medication classified as a Janus kinase (JAK) inhibitor. It works by inhibiting the activity of specific enzymes called Janus kinases, which play a role in the immune system's response. By modulating these enzymes, tofacitinib helps to regulate the immune response, making it useful in the treatment of certain autoimmune diseases. Tofacitinib 11 mg is a extended release tablet.